About a third of lung transplant patients with cystic fibrosis receive elexacaftor-tezacaftor-ivacaftor; use is higher among ...

With a baby on the way, Nathan Kirkland was facing a rare, aggressive form of bile duct cancer. Kirkland’s bills piled up as ...

A new AHA statement highlights research on multidimensional sleep health and its impact on cardiovascular health and says ...

While many believe the agents to be potential game changers, evidence is still lacking in psoriatic disease, and experts urge ...

A new review urges oncology researchers to treat patient-reported outcomes as core trial endpoints — not just secondary stats ...

Two decades of advancement in public health and community strategies regarding cardiac arrest response has paid off with more ...

Long-term exposure to particulate matter and traffic-related air pollution is linked to risk for meningioma, a tumor of the ...

Many medical education programs are finding ways to engage residents and students early and often to try and stave off mental ...

Patients with idiopathic intracranial hypertension who use a GLP-1 receptor agonist are less likely to experience symptoms, require medications, or undergo surgery.

A retrospective review shows that dermatologic patients treated with mycophenolate mofetil face a significantly lower incidence of malignancy than transplant recipients.

Tirzepatide improves outcomes in patients with obesity-related HFpEF regardless of the severity of their baseline BMI or fat ...

All told, the National Institutes of Health (NIH) and the National Science Foundation withdrew or placed on hold almost $4 ...